Amylyx
Patients dismayed as FDA advisors narrowly reject Amylyx’ ALS drug
Phil Taylor
Amylyx, amyotrophic lateral sclerosis, fda, neurodegenerative disease, neurology
0 Comment
X
Patients dismayed as FDA advisors narrowly reject Amylyx’ ALS drug
https://pharmaphorum.com/news/patients-dismayed-as-fda-advisors-narrowly-reject-amylyx-als-drug/
Amylyx slumps on non-committal FDA reviewer assessment of ALS drug
Phil Taylor
Amylyx, amyotrophic lateral sclerosis, central nervous system, neurodegenerative disease
0 Comment
X
Amylyx slumps on non-committal FDA reviewer assessment of ALS drug
https://pharmaphorum.com/news/amylyx-slumps-on-non-committal-fda-reviewer-assessment-of-als-drug/
Amylyx preps filing for its ALS drug after FDA feedback
Phil Taylor
Amylyx, amyotrophic lateral sclerosis, central nervous system, neurology
0 Comment
X
Amylyx preps filing for its ALS drug after FDA feedback
https://pharmaphorum.com/news/amylyx-preps-filing-for-its-als-drug-after-fda-feedback/